Annalisa McGann, chair of London's esteemed Clarence Hall University, together with all the university's board must make a determination about whether to return a large monetary donation from the Natour Charitable Foundation, which was founded and run by a recent grad who was also the son of the leader of a corrupt, authoritarian regime in an oil-rich area.
Almost two-thirds of the cash had been invested in an innovative leukemia drug which could substantially increase patients' likelihood of survival; the balance was earmarked for an endowment fund for low income students. Each course of action- giving back the entire sum keeping the money, or returning the unspent cash - had complex outcomes, mainly in the current environment in which all British universities were afflicted financially and there was nationwide student conflict over mounting university costs. The British press, by revealing the association amid Natour and Clarence Hall, had forced the administration's hand, and the board and McGann needed to make a fast decision after considering several complicating factors.
PUBLICATION DATE: September 24, 2012 PRODUCT #: UV6545-HCB-ENG
This is just an excerpt. This case is about LEADERSHIP & MANAGING PEOPLE
Related Case Solutions & Analyses:
Data to Knowledge to Results: Building an Analytic Capability
Four Seasons Hotels and Resorts
VertiSoft Inc.: Raising the Bar
Manufacturing at ALZA: The Right Prescription (B)
Leader-as-Architect: Alignment
C&F Consulting, Inc.
Start with why how great leaders inspire everyone to take action
Arck Systems
Rotary Cove Beach
Continental Airlines: The Go Forward Plan
